$192.5 million U.S. government contract will help fund center of excellence to boost domestic supply of critically needed laboratory plastics WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will build a state-of-the-art manufacturing facility in Mebane, N.C. The site is part of a recently announced co-investment with the U.S. government – a $192.5 million contract [...]

Company appoints industry veterans from Qiagen and PerkinElmer BRANFORD, Conn. -- IsoPlexis (NASDAQ: ISO), the leader in functional single-cell proteomics, today announced the appointment of two new leadership positions at the company. Michelle Reid, Ph.D. joins IsoPlexis as VP of Service and Support, and Anthony Catalano joins as the Senior VP of Operations. With these [...]

New England Journal of Medicine publication showcases technology-driven variant detection platforms in accurately identifying causative genetic mutations OAKLAND, Calif. -- The New England Journal of Medicine has published findings from a pilot study that has shown how whole genome sequencing (WGS) uncovered new diagnoses for patients across the broadest range of rare diseases. The identification and prioritization [...]

ROCKVILLE, Md. -- Psomagen, Inc., a North American sequencing-based contract laboratory service and data analysis provider with both CLIA-certified and CAP-accredited facilities, has partnered with OlinkProteomics, which offers an innovative DNA-coupled immunoassay that identifies and quantifies protein biomarkers in clinical samples. The partnership enables end-to-end multi-omics clinical studies, a step that will enable a whole new [...]

Investment from Apposite Capital LLP will accelerate CrestOptics’ commercial expansion into new markets globally, and enable further development of innovative cell imaging products Rome, IT: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced it has been acquired through a majority shareholding by Apposite Capital LLP, [...]

Streamlines Operations to Reduce Hands-On Time, Accelerate Results Broad Menu of Applications with Automated Workflow Providing Sample-to-Answer Solutions on a Single Platform SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of Biomark™ X, the latest generation [...]

Asynt has introduced two new innovative kits for scale-up laboratories looking to minimise downtime when changing between different glass reactor vessels. Offering the flexibility to work with glass reactors from different manufacturers, the new ReactoMate Quick-release Couplings allow you to securely attach or detach flexible hosing to your DN or KF glassware in just seconds [...]

Genomenon to Make Variant Data on ENPP1 Deficiency Available to Genetic Testing Labs Across the World Ann Arbor, Michigan – Genomenon, Inc. ® , an AI-driven genomics company, announced a partnership with Inozyme Pharma to make critical information readily accessible to genetic testing labs and clinicians. This information will help inform diagnosis and thus treatment [...]

Novel screening tool enables rapid measurement of immune response T cell receptors resulting from disease and therapeutic response SEATTLE -- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® TCR Diversity Panel and companion cloud-based TCR analysis report created for [...]

ZEISS is a founding member of the Kompetenzzentrum Biointelligenz e.V. and will support creating value and developing innovations with biointelligence. Together with leading research institutions from the Stuttgart area, ZEISS intends to advance the sustainable transformation of the economy and society. Oberkochen, Germany -- On 25 June 2021, ZEISS signed the charter for the Kompetenzzentrum [...]